Collaborations & PartnershipsGlobalPress Release Children’s Tumor Foundation’s Montse Montaner Joins CureAge Therapeutics
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research CureAge Therapeutics Launches to Advance Genetic Therapies for Neurofibromatosis
Collaborations & PartnershipsFeatured EUNF1Press ReleaseScience & ResearchTop Story Children’s Tumor Foundation and CureNFwithJack Announce Next Phase of the Groundbreaking Biomarker Project for NF1 Tumor Detection
Collaborations & PartnershipsFeaturedNF1Story of NF Give for a Fighting Chance: Lashonda’s Story and the Promise of Biomarker Research
Collaborations & PartnershipsCTF in the NewsFeaturedFeatured EUNF2-SWNPublicationsScience & Research From Discovery to Impact: How Collaboration Unlocked Brigatinib for NF2-Related Schwannomatosis
Collaborations & PartnershipsFeaturedFeatured EUNF2-SWNPress ReleaseScience & Research New Meningioma model in development in CTF Preclinical Hub Unlocks Opportunities for NF2-SWN Brain Tumor Therapies
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaScience & Research FDA Grants Fast Track Designation to Healx NF1 Treatment
Collaborations & PartnershipsFeaturedFeatured EUNF ConferenceScience & Research 2024 Global NF Conference Highlights